DE60210266D1 - Verfahren zum nachweis von modulatoren einer sekretaseaktivität - Google Patents

Verfahren zum nachweis von modulatoren einer sekretaseaktivität

Info

Publication number
DE60210266D1
DE60210266D1 DE60210266T DE60210266T DE60210266D1 DE 60210266 D1 DE60210266 D1 DE 60210266D1 DE 60210266 T DE60210266 T DE 60210266T DE 60210266 T DE60210266 T DE 60210266T DE 60210266 D1 DE60210266 D1 DE 60210266D1
Authority
DE
Germany
Prior art keywords
secretase activity
detecting modulators
modulators
detecting
secretase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60210266T
Other languages
English (en)
Other versions
DE60210266T2 (de
Inventor
Alcide Barberis
Michael Middendorp
Urs Luethi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esbatech a Novartis Co LLC
Original Assignee
Esbatech AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esbatech AG filed Critical Esbatech AG
Publication of DE60210266D1 publication Critical patent/DE60210266D1/de
Application granted granted Critical
Publication of DE60210266T2 publication Critical patent/DE60210266T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60210266T 2002-04-18 2002-04-18 Verfahren zum nachweis von modulatoren einer sekretaseaktivität Expired - Fee Related DE60210266T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2002/001342 WO2003087842A1 (en) 2002-04-18 2002-04-18 Method for the identification of modulators of a secretase activity

Publications (2)

Publication Number Publication Date
DE60210266D1 true DE60210266D1 (de) 2006-05-18
DE60210266T2 DE60210266T2 (de) 2007-01-11

Family

ID=29227360

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60210266T Expired - Fee Related DE60210266T2 (de) 2002-04-18 2002-04-18 Verfahren zum nachweis von modulatoren einer sekretaseaktivität

Country Status (6)

Country Link
US (1) US20060068388A1 (de)
EP (1) EP1495329B1 (de)
AU (1) AU2002253468B2 (de)
CA (1) CA2482824A1 (de)
DE (1) DE60210266T2 (de)
WO (1) WO2003087842A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60324207D1 (de) * 2003-10-24 2008-11-27 Oncalis Ag Verfahren zur identifizierung und/oder validierung von rezeptortyrosinkinase-inhibitoren
EP1734039A1 (de) * 2005-06-13 2006-12-20 Esbatech AG Arylharnstoffverbindungen als BETA-Secretase-Hemmer
WO2006133588A1 (en) * 2005-06-13 2006-12-21 Oncalis Ag ARYL UREA COMPOUNDS AS β-SECRETASE INHIBITORS
US20100040546A1 (en) * 2008-08-13 2010-02-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Biological targeting compositions and methods of using the same
US20100042072A1 (en) * 2008-08-13 2010-02-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Biological targeting compositions and methods of using the same
US8211656B2 (en) 2008-08-13 2012-07-03 The Invention Science Fund I, Llc Biological targeting compositions and methods of using the same
US20120034157A1 (en) * 2010-08-03 2012-02-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Artificial cells
EP4170031A1 (de) 2012-10-23 2023-04-26 Caris Science, Inc. Aptamere und verwendungen davon
US10942184B2 (en) 2012-10-23 2021-03-09 Caris Science, Inc. Aptamers and uses thereof
AU2013361323B2 (en) 2012-12-19 2018-09-06 Caris Science, Inc. Compositions and methods for aptamer screening
CN108004198B (zh) * 2016-10-28 2021-07-16 华中农业大学 基于icam-1信号通路的高通量药物筛选模型的建立方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083693A (en) * 1996-06-14 2000-07-04 Curagen Corporation Identification and comparison of protein-protein interactions that occur in populations
DE19641180A1 (de) * 1996-09-24 1998-03-26 Schering Ag Verfahren zur Darstellung von APP-Sekretase Modulation und deren Verwendung als Mittel zur Behandlung der Alzheimer'schen Erkrankung
DE19856261C1 (de) * 1998-12-07 2000-03-30 Hoechst Marion Roussel De Gmbh Aß-Peptid Screening Assay
DE19920514A1 (de) * 1999-05-05 2000-11-16 Boehringer Ingelheim Pharma Methoden zur Auffindung von Proteasen, die spezifisch membrangebundene Substrate spalten
US20020025508A1 (en) * 2000-01-06 2002-02-28 Katja Fechteler Process for finding a protease inhibitor
WO2001062897A1 (en) * 2000-02-25 2001-08-30 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Presenilin deficient multipotent cell lines and screening methods for intramembrane regulated proteolytic activities using these lines
US6333167B1 (en) * 2000-03-10 2001-12-25 American Home Products Corp. Methods and reagents for identifying inhibitors of proteolysis of membrane-associated proteins
AU2000238331A1 (en) * 2000-04-05 2001-10-15 Esbatech Ag Method for identify polypeptides with protease activity
DE60134230D1 (de) * 2000-07-19 2008-07-10 Pharmacia & Upjohn Co Llc Substraten und nachweise zur wirksamkeit von beta-secretase
AU2001291524A1 (en) * 2000-09-19 2002-04-02 Christophe Dutordoir Automatic receipt confirmation system for electronic mail

Also Published As

Publication number Publication date
WO2003087842A1 (en) 2003-10-23
AU2002253468B2 (en) 2008-04-03
EP1495329A1 (de) 2005-01-12
DE60210266T2 (de) 2007-01-11
EP1495329B1 (de) 2006-03-29
US20060068388A1 (en) 2006-03-30
AU2002253468A1 (en) 2003-10-27
CA2482824A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
ATA8612001A (de) Verfahren zum testen von software
DE60017367D1 (de) Verfahren zum bohren
DE50305813D1 (de) Verfahren zum Begrenzen der Krafteinwirkung eines Roboterteils
DE50305837D1 (de) Verfahren zum betrieb einer gasturbogruppe
DE50303416D1 (de) Verfahren und Einrichtung zum Ermitteln der Funktionsfähigkeit einer Speicherbatterie
DE602004000727T8 (de) Verfahren zum Aufbringen einer magnetostriktiven Beschichtung
DE602005016759D1 (de) Verfahren und Vorrichtung zum Betreiben einer Kette von Ladungshaftstellen-Speicherzellen
DE50209742D1 (de) Verfahren zum betrieb einer gasturbogruppe
DE502006008545D1 (de) Verfahren zum Erfassen einer Konfiguration von mehreren Hubeinrichtungen in einem Hubsystem
ATA8712002A (de) Verfahren und anordnung zum raschen verbinden und lösen von miteinander verbindbaren elementen
DE60210266D1 (de) Verfahren zum nachweis von modulatoren einer sekretaseaktivität
DE60318432D1 (de) Verfahren und vorrichtungen zum umsetzen von farbwerten
DE50208275D1 (de) Verfahren zur Überprüfung der Struktur von Durchgangslöchern eines Bauteils
DE10391571D2 (de) Vorrichtung und Verfahren zum Überwachen einer Kupplung
DE602004009151D1 (de) System, Gerät und Verfahren zum Bestimmen einer Verbindungsübereinkunft
DE50001880D1 (de) Verfahren zum vermessen von einer handhabungsvorrichtung
DE50305460D1 (de) Verfahren zum Betreiben einer Geschirrspülmaschine und entsprechende Geschirrspülmaschine
DE10253337B4 (de) Verfahren zum Nachweis einer Nukleinsäure
DE60125471D1 (de) Verfahren zum Anwenden von chemischen Befestigungskleber
DE50303913D1 (de) Verfahren zum Ubertragen von ein bewegliches Objekt betreffenden Standorten
DE112005001345A5 (de) Verfahren zum Aktivieren einer Anfahrhilfe
DE60314310D1 (de) Zentrifuge und Verfahren zum Entleeren einer Zentrifuge
DE10392746D2 (de) Verfahren und Vorrichtung zum Beleimen einer Wabenstruktur
DE60308272D1 (de) Verfahren zum Wiederverbinden eines gelösten Teils
DE60015956D1 (de) Verfahren zum auftragen von abdichtungsmittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee